MLchartDataset catalogue

canagliflozin

Term · Oncology and biomedicine · MLC-T-ONC-012214

A C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia.

Table 1. Record
IdentifierMLC-T-ONC-012214
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-012214",
  "term": "canagliflozin",
  "field": "Oncology and biomedicine",
  "definition": "A C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/canagliflozin/"
}

Record 4,063 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.